Small Molecule Innovator CDMO Market: Aims for Staggering US$89.43 Billion Valuation in 2033
As pharmaceutical companies increasingly outsource their small molecule drug development and manufacturing needs to Contract Development and Manufacturing Organizations (CDMOs), this market is experiencing significant expansion.